These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 3535621)

  • 21. Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study.
    Schurch B; de Sèze M; Denys P; Chartier-Kastler E; Haab F; Everaert K; Plante P; Perrouin-Verbe B; Kumar C; Fraczek S; Brin MF;
    J Urol; 2005 Jul; 174(1):196-200. PubMed ID: 15947626
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and tolerability of solifenacin in elderly subjects with overactive bladder syndrome: a pooled analysis.
    Wagg A; Wyndaele JJ; Sieber P
    Am J Geriatr Pharmacother; 2006 Mar; 4(1):14-24. PubMed ID: 16730617
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Terodiline in the treatment of urinary frequency and motor urge incontinence. A controlled multicentre trial.
    Peters D
    Scand J Urol Nephrol Suppl; 1984; 87():21-33. PubMed ID: 6399953
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Safety and tolerability of tolterodine for the treatment of overactive bladder in men with bladder outlet obstruction.
    Abrams P; Kaplan S; De Koning Gans HJ; Millard R
    J Urol; 2006 Mar; 175(3 Pt 1):999-1004; discussion 1004. PubMed ID: 16469601
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Urinary incontinence in castrated bitches. 2. Diagnosis and treatment].
    Arnold S
    Schweiz Arch Tierheilkd; 1997; 139(7):319-24. PubMed ID: 9281063
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Estrogen therapy in the management of urinary incontinence in postmenopausal women: a meta-analysis. First report of the Hormones and Urogenital Therapy Committee.
    Fantl JA; Cardozo L; McClish DK
    Obstet Gynecol; 1994 Jan; 83(1):12-8. PubMed ID: 8272292
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A double-blind trial of fentonium bromide in the treatment of incontinent unstable bladder.
    Milani R; Merlo E; Scalambrino S; Viganò R
    Int J Clin Pharmacol Ther Toxicol; 1986 Aug; 24(8):421-4. PubMed ID: 3531034
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Efficacy, tolerance and acceptability of Incontex in spayed bitches with urinary incontinence].
    Burgherr T; Reichler I; Hung L; Hubler M; Arnold S
    Schweiz Arch Tierheilkd; 2007 Jul; 149(7):307-13. PubMed ID: 17702490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical efficacy and safety of tolterodine compared to placebo in detrusor overactivity.
    Millard R; Tuttle J; Moore K; Susset J; Clarke B; Dwyer P; Davis BE
    J Urol; 1999 May; 161(5):1551-5. PubMed ID: 10210394
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Darifenacin, an M3 selective receptor antagonist, is an effective and well-tolerated once-daily treatment for overactive bladder.
    Haab F; Stewart L; Dwyer P
    Eur Urol; 2004 Apr; 45(4):420-9; discussion 429. PubMed ID: 15041104
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urethral sphincteric insufficiency in postmenopausal females: treatment with phenylpropanolamine and estriol separately and in combination. A urodynamic and clinical evaluation.
    Beisland HO; Fossberg E; Moer A; Sander S
    Urol Int; 1984; 39(4):211-6. PubMed ID: 6541387
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of results of preoperative urodynamic measurements in nine dogs with ectopic ureters.
    Lane IF; Lappin MR; Seim HB
    J Am Vet Med Assoc; 1995 May; 206(9):1348-57. PubMed ID: 7775247
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Achieving continence with antimuscarinic therapy for overactive bladder: effects of baseline incontinence severity and bladder diary duration.
    Wein AJ; Khullar V; Wang JT; Guan Z
    BJU Int; 2007 Feb; 99(2):360-3. PubMed ID: 17155987
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antidiuresis: a new concept in managing female daytime urinary incontinence.
    Robinson D; Cardozo L; Akeson M; Hvistendahl G; Riis A; Norgaard JP
    BJU Int; 2004 May; 93(7):996-1000. PubMed ID: 15142150
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Randomized double-blind trial of terodiline in the treatment of urge incontinence in women.
    Norton P; Karram M; Wall LL; Rosenzweig B; Benson JT; Fantl JA
    Obstet Gynecol; 1994 Sep; 84(3):386-91. PubMed ID: 8058236
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of pelvic floor muscle training on strength and predictors of response in the treatment of urinary incontinence.
    Theofrastous JP; Wyman JF; Bump RC; McClish DK; Elser DM; Bland DR; Fantl JA
    Neurourol Urodyn; 2002; 21(5):486-90. PubMed ID: 12232886
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of the success rates of Burch colposuspension in relation to Valsalva leak-point pressure.
    Bai SW; Park JH; Kim SK; Park KH
    J Reprod Med; 2005 Mar; 50(3):189-92. PubMed ID: 15841931
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of previous treatment experience and incontinence severity on the placebo response of stress urinary incontinence.
    Yalcin I; Bump RC
    Am J Obstet Gynecol; 2004 Jul; 191(1):194-7. PubMed ID: 15295364
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A pooled analysis of three phase III studies to investigate the efficacy, tolerability and safety of darifenacin, a muscarinic M3 selective receptor antagonist, in the treatment of overactive bladder.
    Chapple C; Steers W; Norton P; Millard R; Kralidis G; Glavind K; Abrams P
    BJU Int; 2005 May; 95(7):993-1001. PubMed ID: 15839920
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of combined treatment with phenylpropanolamine and estriol, compared with estriol treatment alone, in postmenopausal women with stress urinary incontinence.
    Ahlström K; Sandahl B; Sjöberg B; Ulmsten U; Stormby N; Lindskog M
    Gynecol Obstet Invest; 1990; 30(1):37-43. PubMed ID: 2227611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.